| 2269WuXi Biologics (Cayman) | HK$121.10 | 3.5% | 124.5% | HK$513.2b | HK$147.52 | P/E235.6x | E27.4% | n/a | |
| 6185CanSino Biologics | HK$337.00 | 24.7% | 29.5% | HK$127.8b | HK$428.59 | P/S133.1x | E22.9% | n/a | |
| 1548Genscript Biotech | HK$34.85 | 8.1% | 110.4% | HK$73.1b | HK$25.67 | P/S21.8x | E15.0% | 0% | |
| 9995RemeGen | HK$99.80 | 12.2% | n/a | HK$48.9b | HK$130.48 | P/B11.3x | E50.3% | n/a | |
| 1801Innovent Biologics | HK$79.00 | 3.6% | 65.6% | HK$115.2b | HK$104.28 | P/S23.2x | E53.1% | n/a | |
| 460Sihuan Pharmaceutical Holdings Group | HK$2.73 | 11.4% | 241.3% | HK$25.8b | HK$3.34 | P/E42.3x | E45.7% | 1.9% | |
| 2137Brii Biosciences | HK$25.90 | 15.1% | n/a | HK$18.3b | n/a | P/S50.1x | n/a | n/a | |
| 9939Kintor Pharmaceutical | HK$78.00 | 8.3% | 413.2% | HK$30.2b | HK$69.50 | P/B15.9x | E75.3% | n/a | |
| 2162Keymed Biosciences | HK$67.85 | 9.9% | n/a | HK$19.0b | n/a | P/E-18.7x | n/a | n/a | |
| 9926Akeso | HK$50.30 | 4.4% | 68.2% | HK$41.1b | HK$72.63 | P/S570.2x | E70.8% | n/a | |
| 2171CARsgen Therapeutics Holdings | HK$29.90 | 10.7% | n/a | HK$17.0b | HK$48.72 | P/E-4.6x | n/a | n/a | |
| 6118Austar Lifesciences | HK$18.74 | 11.2% | 380.5% | HK$9.6b | n/a | P/E241.3x | n/a | 0% | |
| 570China Traditional Chinese Medicine Holdings | HK$4.85 | 3.2% | 25.0% | HK$24.4b | HK$5.54 | P/E12.2x | E7.5% | 0% | |
| 2186Luye Pharma Group | HK$4.25 | 5.2% | -13.4% | HK$15.1b | HK$5.91 | P/E15.9x | E19.2% | 0% | |
| 1093CSPC Pharmaceutical Group | HK$10.48 | 0.6% | 3.8% | HK$125.3b | HK$14.11 | P/E19x | E12.5% | 1.7% | |
| 1877Shanghai Junshi Biosciences | HK$52.35 | 1.5% | 2.0% | HK$62.3b | HK$93.43 | P/S12.1x | E5.4% | n/a | |
| 1521Frontage Holdings | HK$6.46 | 4.9% | 56.4% | HK$13.2b | HK$6.64 | P/E97.5x | E24.0% | n/a | |
| 512China Grand Pharmaceutical and Healthcare Holdings | HK$6.19 | 2.5% | -30.8% | HK$22.0b | HK$10.00 | P/E11.9x | S17.6% | 1.8% | |
| 1873Viva Biotech Holdings | HK$8.02 | 3.4% | -9.0% | HK$15.4b | HK$10.39 | P/S15x | E23.8% | 0.3% | |
| 1952Everest Medicines | HK$60.25 | 2.6% | n/a | HK$17.9b | HK$106.44 | P/B2.1x | E92.6% | n/a | |
| 1177Sino Biopharmaceutical | HK$6.69 | 0.3% | -33.1% | HK$125.6b | HK$11.19 | P/E27.4x | E8.4% | 1.2% | |
| 1167Jacobio Pharmaceuticals Group | HK$18.44 | 1.5% | n/a | HK$14.2b | HK$26.05 | P/S12x | S-42.1% | n/a | |
| 3681SinoMab BioScience | HK$3.35 | 6.3% | -5.1% | HK$3.4b | n/a | P/S219.6x | n/a | n/a | |
| 1349Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | HK$4.69 | 3.8% | -21.0% | HK$15.3b | n/a | P/E21.2x | n/a | 1.3% | |